BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21850306)

  • 1. Diversifying the structural architecture of synthetic oligomers: the hetero foldamer approach.
    Roy A; Prabhakaran P; Baruah PK; Sanjayan GJ
    Chem Commun (Camb); 2011 Nov; 47(42):11593-611. PubMed ID: 21850306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally rigid aromatic amino acids as potential building blocks for abiotic foldamers.
    Ramesh VV; Roy A; Vijayadas KN; Kendhale AM; Prabhakaran P; Gonnade R; Puranik VG; Sanjayan GJ
    Org Biomol Chem; 2011 Jan; 9(2):367-9. PubMed ID: 21082121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foldamers with unusual structural architecture from spirobi(indane) building blocks.
    Kendhale AM; Gonnade R; Rajamohanan PR; Hofmann HJ; Sanjayan GJ
    Chem Commun (Camb); 2008 Jun; (22):2541-3. PubMed ID: 18506237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foldamers with heterogeneous backbones.
    Horne WS; Gellman SH
    Acc Chem Res; 2008 Oct; 41(10):1399-408. PubMed ID: 18590282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformationally constrained aliphatic-aromatic amino-acid-conjugated hybrid foldamers with periodic beta-turn motifs.
    Srinivas D; Gonnade R; Ravindranathan S; Sanjayan GJ
    J Org Chem; 2007 Aug; 72(18):7022-5. PubMed ID: 17691737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel foldamer structural architecture from cofacial aromatic building blocks.
    Prabhakaran P; Puranik VG; Chandran JN; Rajamohanan PR; Hofmann HJ; Sanjayan GJ
    Chem Commun (Camb); 2009 Jun; (23):3446-8. PubMed ID: 19503899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BINOL-based foldamers--access to oligomers with diverse structural architectures.
    Baruah PK; Gonnade R; Rajamohanan PR; Hofmann HJ; Sanjayan GJ
    J Org Chem; 2007 Jul; 72(14):5077-84. PubMed ID: 17564462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of urea-linked aromatic oligomers--a route towards convoluted foldamers.
    Mousseau JJ; Xing L; Tang N; Cuccia LA
    Chemistry; 2009 Oct; 15(39):10030-8. PubMed ID: 19746470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foldectures: 3D Molecular Architectures from Self-Assembly of Peptide Foldamers.
    Yoo SH; Lee HS
    Acc Chem Res; 2017 Apr; 50(4):832-841. PubMed ID: 28191927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence-specific unusual (1-->2)-type helical turns in alpha/beta-hybrid peptides.
    Prabhakaran P; Kale SS; Puranik VG; Rajamohanan PR; Chetina O; Howard JA; Hofmann HJ; Sanjayan GJ
    J Am Chem Soc; 2008 Dec; 130(52):17743-54. PubMed ID: 19061328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide mimics by linear arylamides: a structural and functional diversity test.
    Li ZT; Hou JL; Li C
    Acc Chem Res; 2008 Oct; 41(10):1343-53. PubMed ID: 18361513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing structural motifs for clickamers: exploiting the 1,2,3-triazole moiety to generate conformationally restricted molecular architectures.
    Zornik D; Meudtner RM; El Malah T; Thiele CM; Hecht S
    Chemistry; 2011 Feb; 17(5):1473-84. PubMed ID: 21268150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folding-driven synthesis of oligomers.
    Oh K; Jeong KS; Moore JS
    Nature; 2001 Dec 20-27; 414(6866):889-93. PubMed ID: 11780057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enforcing periodic secondary structures in hybrid peptides: a novel hybrid foldamer containing periodic gamma-turn motifs.
    Baruah PK; Sreedevi NK; Gonnade R; Ravindranathan S; Damodaran K; Hofmann HJ; Sanjayan GJ
    J Org Chem; 2007 Jan; 72(2):636-9. PubMed ID: 17221986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond de novo protein design--de novo design of non-natural folded oligomers.
    Cheng RP
    Curr Opin Struct Biol; 2004 Aug; 14(4):512-20. PubMed ID: 15313247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New helical foldamers: heterogeneous backbones with 1:2 and 2:1 alpha:beta-amino acid residue patterns.
    Schmitt MA; Choi SH; Guzei IA; Gellman SH
    J Am Chem Soc; 2006 Apr; 128(14):4538-9. PubMed ID: 16594667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformationally Programmable Chiral Foldamers with Compact and Extended Domains Controlled by Monomer Structure.
    Lockhart Z; Knipe PC
    Angew Chem Int Ed Engl; 2018 Jul; 57(28):8478-8482. PubMed ID: 29737622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residue-based control of helix shape in beta-peptide oligomers.
    Appella DH; Christianson LA; Klein DA; Powell DR; Huang X; Barchi JJ; Gellman SH
    Nature; 1997 May; 387(6631):381-4. PubMed ID: 9163422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic facially amphiphilic antibacterial oligomers with conformationally stiff backbones.
    Tang H; Doerksen RJ; Jones TV; Klein ML; Tew GN
    Chem Biol; 2006 Apr; 13(4):427-35. PubMed ID: 16632255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent display of both α- and β-turns in a model peptide.
    Srinivas D; Vijayadas KN; Gonnade R; Phalgune UD; Rajamohanan PR; Sanjayan GJ
    Org Biomol Chem; 2011 Aug; 9(16):5762-5. PubMed ID: 21720634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.